180 Life Sciences Stock (NASDAQ: ATNF) stock price, news, charts, stock research, profile.
Open | $1.750 |
Close | - |
Volume / Avg. | 77.696K / 102.296K |
Day Range | 1.720 - 2.060 |
52 Wk Range | 1.330 - 27.930 |
Market Cap | $1.492M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 5.05% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of 180 Life Sciences (NASDAQ: ATNF) through any online brokerage.
Other companies in 180 Life Sciences’s space includes: NeuBase Therapeutics (NASDAQ:NBSE), Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX) and Qualigen Therapeutics (NASDAQ:QLGN).
The latest price target for 180 Life Sciences (NASDAQ: ATNF) was reported by Maxim Group on Monday, May 9, 2022. The analyst firm set a price target for 0.00 expecting ATNF to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for 180 Life Sciences (NASDAQ: ATNF) is $1.86 last updated Today at April 18, 2024 at 11:45 AM EDT.
There are no upcoming dividends for 180 Life Sciences.
180 Life Sciences’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for 180 Life Sciences.
180 Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.